Cargando…
New opportunities with biologic treatments in pediatric allergic and respiratory diseases
In the last 20 years, the introduction of monoclonal antibodies has dramatically changed allergic diseases. At present, several monoclonal antibodies are approved for treating asthma, atopic dermatitis, chronic spontaneous urticaria, and chronic sinusitis with nasal polyps in children. Biologics hav...
Autores principales: | Tenero, Laura, Piacentini, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305856/ https://www.ncbi.nlm.nih.gov/pubmed/35080293 http://dx.doi.org/10.1111/pai.13617 |
Ejemplares similares
-
Endotyping allergic rhinitis in children: A machine learning approach
por: Malizia, Velia, et al.
Publicado: (2022) -
Allergic rhinitis, microbiota and passive smoke in children: A pilot study
por: Brindisi, Giulia, et al.
Publicado: (2022) -
Machine learning: A modern approach to pediatric asthma
por: Cilluffo, Giovanna, et al.
Publicado: (2022) -
Role of air pollutants mediated oxidative stress in respiratory diseases
por: Traina, Giovanni, et al.
Publicado: (2022) -
Nutritional status in eosinophilic gastrointestinal disorders: A pediatric case‐control study
por: Votto, Martina, et al.
Publicado: (2022)